Executive Development Programme in Pharmacovigilance: Results Focus
-- ViewingNowThe Executive Development Programme in Pharmacovigilance: Results Focus certificate course is a comprehensive program designed to equip learners with critical skills in pharmacovigilance. This course is vital for professionals seeking to enhance their understanding of drug safety and its role in healthcare and the pharmaceutical industry.
4,466+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Pharmacovigilance: Understanding the primary objectives, principles, and key terminologies in pharmacovigilance. This unit will cover the importance of monitoring drug safety, adverse drug reaction reporting, and risk management.
⢠Regulatory Framework for Pharmacovigilance: An overview of the primary regulatory bodies and guidelines governing pharmacovigilance, including the FDA, EMA, and ICH. This unit will also discuss the importance of complying with global pharmacovigilance regulations.
⢠Pharmacovigilance Risk Management: Understanding the concepts and methods of risk management in pharmacovigilance. This unit will cover signal detection, benefit-risk assessment, and risk minimization strategies.
⢠Pharmacovigilance Systems and Tools: An overview of the various pharmacovigilance systems and tools used for adverse drug reaction reporting, signal detection, and risk management. This unit will discuss the use of safety databases, literature screening tools, and statistical software.
⢠Pharmacovigilance in Clinical Trials: Understanding the role of pharmacovigilance in clinical trials, including the reporting and management of adverse events during clinical trials.
⢠Pharmacovigilance in Drug Development: An overview of the pharmacovigilance activities during different phases of drug development. This unit will cover the importance of pharmacovigilance in drug approval, labeling, and post-marketing surveillance.
⢠Pharmacovigilance in Marketing Authorization Holders: Understanding the responsibilities and obligations of marketing authorization holders in pharmacovigilance. This unit will cover the importance of maintaining pharmacovigilance systems, reporting adverse drug reactions, and conducting periodic safety updates.
⢠Pharmacovigilance Audits and Inspections: An overview of the audits and inspections conducted by regulatory bodies to ensure compliance with pharmacovigilance regulations. This unit will cover the preparation, conduct, and follow-up of pharmacovigilance audits and inspections.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë